rs1341894581
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004826.4(ECEL1):βc.110_155delβ(p.Phe37CysfsTer151) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000571 in 1,383,780 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.00011 ( 0 hom., cov: 33)
Exomes π: 0.000051 ( 0 hom. )
Consequence
ECEL1
NM_004826.4 frameshift
NM_004826.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.70
Genes affected
ECEL1 (HGNC:3147): (endothelin converting enzyme like 1) This gene encodes a member of the M13 family of endopeptidases. Members of this family are zinc-containing type II integral-membrane proteins that are important regulators of neuropeptide and peptide hormone activity. Mutations in this gene are associated with autosomal recessive distal arthrogryposis, type 5D. This gene has multiple pseudogenes on chromosome 2. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-232486498-CAGCCCGGACCGGGCCCCGGTGGCGCTGCGCGCAGCGCCCAACGGGA-C is Pathogenic according to our data. Variant chr2-232486498-CAGCCCGGACCGGGCCCCGGTGGCGCTGCGCGCAGCGCCCAACGGGA-C is described in ClinVar as [Pathogenic]. Clinvar id is 435024.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-232486498-CAGCCCGGACCGGGCCCCGGTGGCGCTGCGCGCAGCGCCCAACGGGA-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ECEL1 | NM_004826.4 | c.110_155del | p.Phe37CysfsTer151 | frameshift_variant | 2/18 | ENST00000304546.6 | |
ECEL1 | NM_001290787.2 | c.110_155del | p.Phe37CysfsTer151 | frameshift_variant | 2/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ECEL1 | ENST00000304546.6 | c.110_155del | p.Phe37CysfsTer151 | frameshift_variant | 2/18 | 1 | NM_004826.4 | P4 | |
ECEL1 | ENST00000409941.1 | c.110_155del | p.Phe37CysfsTer151 | frameshift_variant | 1/17 | 1 | A1 | ||
ECEL1 | ENST00000482346.1 | n.314_359del | non_coding_transcript_exon_variant | 2/17 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000106 AC: 16AN: 151644Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
16
AN:
151644
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000326 AC: 7AN: 21450Hom.: 0 AF XY: 0.000299 AC XY: 4AN XY: 13386
GnomAD3 exomes
AF:
AC:
7
AN:
21450
Hom.:
AF XY:
AC XY:
4
AN XY:
13386
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000511 AC: 63AN: 1232136Hom.: 0 AF XY: 0.0000431 AC XY: 26AN XY: 602972
GnomAD4 exome
AF:
AC:
63
AN:
1232136
Hom.:
AF XY:
AC XY:
26
AN XY:
602972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000106 AC: 16AN: 151644Hom.: 0 Cov.: 33 AF XY: 0.000162 AC XY: 12AN XY: 74044
GnomAD4 genome
AF:
AC:
16
AN:
151644
Hom.:
Cov.:
33
AF XY:
AC XY:
12
AN XY:
74044
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Distal arthrogryposis type 5D Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Medicine Lab, University of California San Francisco | Aug 15, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jul 17, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a likely mechanism of disease in this gene and is associated with distal arthrogryposis, type 5D (MIM#615065). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 (v3) for a recessive condition (16 heterozygotes, 0 homozygotes). (SP) 0701 - Other null variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. There are multiple NMD-predicted variants that have been classified as likely pathogenic or pathogenic (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic by multiple clinical diagnostic laboratories and has been identified in individuals with distal arthrogryposis (ClinVar; PMIDs: 30792901, 33966749, 33060286). (SP) 1102 - Strong phenotype match for this individual. (SP) 1201 - Heterozygous variant detected in trans with a heterozygous likely pathogenic variant, NM_004826.3(ECEL1):c.1783_1788del, p.(Pro595Asp596del), in a recessive disease. (I) 1206 - This variant has been shown to be paternally inherited (by segregation analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 05, 2016 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 03, 2022 | Identified in the presence of a second ECEL1 variant in a patient with arthrogryposis (Scocchia et al., 2019); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 23236030, 23261301, 25099528, 24782201, 25708584, 33743358, 33966749, 30792901, 27535533) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at